{"id": "1356600103352598528", "creation": 1612273643.0, "user_id": "1080074696366977026", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet\n\nHaving 2 different vectors may have helped.\n\n#SputnikV #COVID19 #vaccine\n\nhttps://t.co/ckrAeA1Rzw", "first_save": 1634559108.199414, "hashtags": ["#SPUTNIKV", "#COVID19", "#VACCINE"]}